HEALTHSTORY 726· JULY 17, 2026

Access to testosterone medication in the U.S. draws scrutiny in health media

The question of who can legally obtain testosterone, a hormone medication prescribed for a range of medical conditions, surfaced this week in STAT's Morning Rounds, a free daily newsletter covering health and medicine. The newsletter…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 725$44 million Chantix settlement opens claims for health plans and patients who paid retail NEXT STORY 727 →Investors in ADMA Biologics reminded of class action deadlines

Keep reading

More from the desk.

46HEALTH

Readers debate doctor credentials, AI in the exam room, and surrogacy in STAT's First Opinion letters

When physician credentials, artificial intelligence in the exam room, and surrogacy generated enough reader mail to warrant a public reply, STAT published the letters. The health and life sciences publ

health1 MIN

67HEALTH

A drug for Angelman syndrome failed its final trial. Researchers say the science is not done.

A late-stage trial for an experimental Angelman syndrome drug came back negative this week, dealing a major blow to patients and to the company behind it. Late-stage, in clinical testing, means the final ro

health2 MIN

72HEALTH

Novartis heart drug pelacarsen fails its largest clinical trial

A closely watched drug for a common heart disease risk factor has failed in its biggest test. Pelacarsen, developed by Novartis, targets Lp(a), a particle made from lipids and proteins whose elevated concentrations in the blood raise the…

health1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk